477 related articles for article (PubMed ID: 21430656)
1. The use of induced pluripotent stem cells in drug development.
Inoue H; Yamanaka S
Clin Pharmacol Ther; 2011 May; 89(5):655-61. PubMed ID: 21430656
[TBL] [Abstract][Full Text] [Related]
2. iPSC technology: platform for drug discovery. Point.
Ellis J; Bhatia M
Clin Pharmacol Ther; 2011 May; 89(5):639-41. PubMed ID: 21512521
[TBL] [Abstract][Full Text] [Related]
3. The use of human embryonic stem cells in drug discovery. Counterpoint.
Esteso P; Gearhart JD
Clin Pharmacol Ther; 2011 May; 89(5):641-3. PubMed ID: 21512522
[No Abstract] [Full Text] [Related]
4. Induced pluripotent stem cells: an emerging theranostics platform.
Nelson TJ; Terzic A
Clin Pharmacol Ther; 2011 May; 89(5):648-50. PubMed ID: 21512525
[TBL] [Abstract][Full Text] [Related]
5. An introduction to induced pluripotent stem cells.
Hanley J; Rastegarlari G; Nathwani AC
Br J Haematol; 2010 Oct; 151(1):16-24. PubMed ID: 20666774
[TBL] [Abstract][Full Text] [Related]
6. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
7. Human induced pluripotent stem cells: the past, present, and future.
Hussein SM; Nagy K; Nagy A
Clin Pharmacol Ther; 2011 May; 89(5):741-5. PubMed ID: 21430659
[No Abstract] [Full Text] [Related]
8. Induced pluripotent stem cells in research and therapy.
Teoh HK; Cheong SK
Malays J Pathol; 2012 Jun; 34(1):1-13. PubMed ID: 22870592
[TBL] [Abstract][Full Text] [Related]
9. Human pluripotent stem cells for disease modelling and drug screening.
Maury Y; Gauthier M; Peschanski M; Martinat C
Bioessays; 2012 Jan; 34(1):61-71. PubMed ID: 22038777
[TBL] [Abstract][Full Text] [Related]
10. The bioethics of iPS cell-based drug discovery.
Hyun I
Clin Pharmacol Ther; 2011 May; 89(5):646-7. PubMed ID: 21512524
[TBL] [Abstract][Full Text] [Related]
11. Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery.
Murata M; Tohyama S; Fukuda K
Pharmacol Ther; 2010 May; 126(2):109-18. PubMed ID: 20156482
[TBL] [Abstract][Full Text] [Related]
12. Viable iPSC mice: a step closer to therapeutic applications in humans?
Betts DH; Kalionis B
Mol Hum Reprod; 2010 Feb; 16(2):57-62. PubMed ID: 19952032
[TBL] [Abstract][Full Text] [Related]
13. Exploiting pluripotency for therapeutic gain.
Deng W
Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
[TBL] [Abstract][Full Text] [Related]
14. Human stem cells for modeling neurological disorders: accelerating the drug discovery pipeline.
Crook JM; Kobayashi NR
J Cell Biochem; 2008 Dec; 105(6):1361-6. PubMed ID: 18980214
[TBL] [Abstract][Full Text] [Related]
15. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
Das AK; Pal R
J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
[TBL] [Abstract][Full Text] [Related]
16. Comparison of reprogramming efficiency between transduction of reprogramming factors, cell-cell fusion, and cytoplast fusion.
Hasegawa K; Zhang P; Wei Z; Pomeroy JE; Lu W; Pera MF
Stem Cells; 2010 Aug; 28(8):1338-48. PubMed ID: 20572011
[TBL] [Abstract][Full Text] [Related]
17. Stem cells. Diseases in a dish take off.
Vogel G
Science; 2010 Nov; 330(6008):1172-3. PubMed ID: 21109645
[No Abstract] [Full Text] [Related]
18. Concise review: The magic act of generating induced pluripotent stem cells: many rabbits in the hat.
Mostoslavsky G
Stem Cells; 2012 Jan; 30(1):28-32. PubMed ID: 21948613
[TBL] [Abstract][Full Text] [Related]
19. Concise review: drug discovery in the age of the induced pluripotent stem cell.
Ko HC; Gelb BD
Stem Cells Transl Med; 2014 Apr; 3(4):500-9. PubMed ID: 24493856
[TBL] [Abstract][Full Text] [Related]
20. Can controlled cellular reprogramming be achieved using microRNAs?
Sun X; Fu X; Han W; Zhao Y; Liu H
Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
